BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Klaiber U, Hackert T. Conversion Surgery for Pancreatic Cancer-The Impact of Neoadjuvant Treatment. Front Oncol. 2019;9:1501. [PMID: 31993372 DOI: 10.3389/fonc.2019.01501] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Kirkpatrick S, Gillies G, Underwood P, Cioffi J, Trevino JG, Hughes SJ. Biliary intervention rates during neoadjuvant therapy for adenocarcinoma of the pancreatic head. HPB (Oxford) 2021;23:1196-200. [PMID: 33388244 DOI: 10.1016/j.hpb.2020.11.1147] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Mataki Y, Kurahara H, Idichi T, Tanoue K, Hozaka Y, Kawasaki Y, Iino S, Maemura K, Shinchi H, Ohtsuka T. Clinical Benefits of Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Institution, Retrospective Analysis. Cancers (Basel) 2021;13:1057. [PMID: 33801465 DOI: 10.3390/cancers13051057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Heckler M, Hackert T. Surgery for locally advanced pancreatic ductal adenocarcinoma-is it only about the vessels? J Gastrointest Oncol 2021;12:2503-11. [PMID: 34790411 DOI: 10.21037/jgo-20-313] [Reference Citation Analysis]
4 Makino I, Tajima H, Kitagawa H, Gabata R, Okazaki M, Shinbashi H, Ohbatake Y, Nakanuma S, Saito H, Yamaguchi T, Terai S, Okamoto K, Sakai S, Kinoshita J, Nakamura K, Ninomiya I, Fushida S, Ohta T. Verification of Resectability Status for Pancreatic Cancer: Radiological and Pathological Analysis of Patients Undergoing Pancreatoduodenectomy With Combined Resection of the Superior Mesenteric Artery. Pancreas 2022;51:35-40. [PMID: 35195593 DOI: 10.1097/MPA.0000000000001964] [Reference Citation Analysis]
5 Huart C, Chen JW, Le Calvé B, Michiels C, Wéra AC. Could Protons and Carbon Ions Be the Silver Bullets Against Pancreatic Cancer? Int J Mol Sci 2020;21:E4767. [PMID: 32635552 DOI: 10.3390/ijms21134767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Meyer A, Carvalho BJ, Medeiros KA, Pipek LZ, Nascimento FS, Suzuki MO, Munhoz JV, Iuamoto LR, Carneiro-D'Alburquerque LA, Andraus W. Change in neoadjuvant chemotherapy could alter the prognosis of patients with pancreatic adenocarcinoma: A case report. World J Clin Cases 2021; 9(14): 3418-3423 [PMID: 34002153 DOI: 10.12998/wjcc.v9.i14.3418] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Schmidt T, Strobel O, Schneider M, Diener MK, Berchtold C, Mihaljevic AL, Mehrabi A, Müller-Stich BP, Hackert T, Büchler MW. Cavernous transformation of the portal vein in pancreatic cancer surgery-venous bypass graft first. Langenbecks Arch Surg 2020;405:1045-50. [PMID: 32915294 DOI: 10.1007/s00423-020-01974-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Mehta S, Bhimani N, Gill AJ, Samra JS, Sahni S, Mittal A. Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas. Front Oncol 2021;11:708963. [PMID: 34290990 DOI: 10.3389/fonc.2021.708963] [Reference Citation Analysis]